Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 2.72 g/t Au over 139.9 metres at Golden Summit (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Silo Pharma Inc SILO

Healthcare Psychedelics
Silo Pharma, Inc. is a developmental stage biopharmaceutical company. The Company is focused on developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It is engaged in acquiring and/or developing intellectual property or technology rights from universities and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SILO)

Silo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical Trial

GlobeNewswire 13 days ago

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

GlobeNewswire January 2, 2025

Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia

GlobeNewswire December 18, 2024

Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management

GlobeNewswire November 29, 2024

Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders

GlobeNewswire November 18, 2024

Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant

GlobeNewswire October 31, 2024

Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD

GlobeNewswire September 10, 2024

Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic

GlobeNewswire August 14, 2024

Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide

GlobeNewswire August 7, 2024
View More News ››

Opinion & Analysis (NDAQ:SILO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SILO)

Buy buddy buy because it's taking off this morning.

So that you guys should be on-board with this stock already.
coolfooldumbguy - 13 days ago

Silo Pharma Initiates Pharmacokinetic and Tolerability Study

NEWS: $SILO Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and FibromyalgiaKey...
whytestocks - December 18, 2024

Silo Pharma Enters Joint Development Agreement for SP-26 Ket

NEWS: $SILO Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain ManagementPrototype...
whytestocks - November 29, 2024

Silo Pharma Announces Positive Results for Novel SPC-15 Trea

Just In: $SILO Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related DisordersDual-action approach...
whytestocks - November 18, 2024

Silo Pharma Announces Completion of FDA Pre-IND Meeting to A

News; $SILO Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSDProposal...
whytestocks - September 10, 2024

Silo Pharma, Inc. (NASDAQ:SILO) &#8211; A Promising Developm

http://beyondspx.com/2024/08/02/silo-pharma-inc-nasdaqsilo-a-promising-developmental-stage-biopharmaceutical-company/
MikeTester - August 3, 2024
View more Bullboard ››

Viva Gold Corp.

Viva Gold Corp.

Viva Gold Corp. is a Canada-based gold exploration and development company, The Company’s business is the acquisition ...
View More »